377 related articles for article (PubMed ID: 31501249)
1. Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates.
Gregory AE; van Schaik EJ; Russell-Lodrigue KE; Fratzke AP; Samuel JE
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31501249
[No Abstract] [Full Text] [Related]
2. Soluble antigens derived from
Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
Waag DM; England MJ; Pitt ML
Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
[TBL] [Abstract][Full Text] [Related]
4. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
[TBL] [Abstract][Full Text] [Related]
5. Multivalent vaccines demonstrate immunogenicity and protect against
Jan S; Fratzke AP; Felgner J; Hernandez-Davies JE; Liang L; Nakajima R; Jasinskas A; Supnet M; Jain A; Felgner PL; Davies DH; Gregory AE
Front Immunol; 2023; 14():1192821. PubMed ID: 37533862
[TBL] [Abstract][Full Text] [Related]
6. Promiscuous
Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
Front Immunol; 2019; 10():207. PubMed ID: 30828331
[No Abstract] [Full Text] [Related]
7. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
[TBL] [Abstract][Full Text] [Related]
8. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
Front Immunol; 2021; 12():653092. PubMed ID: 33815413
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.
Russell-Lodrigue KE; Zhang GQ; McMurray DN; Samuel JE
Infect Immun; 2006 Nov; 74(11):6085-91. PubMed ID: 17057087
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
Deringer JR; Chen C; Samuel JE; Brown WC
Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
[TBL] [Abstract][Full Text] [Related]
11. The Feasibility of Using
Kumaresan V; Alam S; Zhang Y; Zhang G
Front Immunol; 2021; 12():754690. PubMed ID: 34795669
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
[TBL] [Abstract][Full Text] [Related]
13. Pathologic changes and immune responses against Coxiella burnetii in mice following infection via non-invasive intratracheal inoculation.
Hu X; Yu Y; Feng J; Fu M; Dai L; Lu Z; Luo W; Wang J; Zhou D; Xiong X; Wen B; Zhao B; Jiao J
PLoS One; 2019; 14(12):e0225671. PubMed ID: 31805090
[TBL] [Abstract][Full Text] [Related]
14. Components of protective immunity.
Zhang G; Zhang Y; Samuel JE
Adv Exp Med Biol; 2012; 984():91-104. PubMed ID: 22711628
[TBL] [Abstract][Full Text] [Related]
15. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
Wilhelmsen CL; Waag DM
Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii.
Waag DM; Byrne WR; Estep J; Gibbs P; Pitt ML; Banfield CM
Lab Anim Sci; 1999 Dec; 49(6):634-8. PubMed ID: 10638499
[TBL] [Abstract][Full Text] [Related]
18. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of
Sluder AE; Raju Paul S; Moise L; Dold C; Richard G; Silva-Reyes L; Baeten LA; Scholzen A; Reeves PM; Pollard AJ; Garritsen A; Bowen RA; De Groot AS; Rollier C; Poznansky MC
Front Immunol; 2022; 13():901372. PubMed ID: 35651616
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.
Ledbetter L; Cherla R; Chambers C; Zhang Y; Zhang G
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
